Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$24.7M
-81.4% from 2023
Prescriptions
12K
$2,008.74 per claim
Patients
2,969
2,140 prescribers
Total spending, 2024
$24.7M
$8,329.21 per patient
Medicare prescription drug plans paid $24.7M for Prezista in 2024, for 12,314 prescriptions and refills to 2,969 patients (down 81.4% from 2023). The average cost per claim was $2,008.74.
New York had the highest Medicare cost for Prezista in 2024: $4.9M for 2,405 claims, followed by Florida ($2.7M).
Joseph P McGowan, infectious disease in Manhasset, NY, had the highest Medicare cost for Prezista in 2024: 88 claims costing $178K.
Prezista is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Janssen Product.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Joseph P McGowan Manhasset, NY | Infectious Disease | 88 | 12 | $178K |
| Lawrence G Hitzeman New York, NY | Internal Medicine | 61 | Under 11 | $156K |
| Cecilia J Yoon |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 5,029 | 59,946 | 8,161 | $133.0M |
| 2024 | 2,140 | 12,314 | 2,969 | $24.7M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 78 |
| Under 11 |
| $147K |
| Karen F Brudney New York, NY | Internal Medicine | 72 | 15 | $135K |
| Quenyatta Echols-Williams Hattiesburg, MS | Internal Medicine | 50 | 13 | $107K |
| Clifford J Gunthel Atlanta, GA | Infectious Disease | 64 | 22 | $107K |
| David W Keller III Monterey, CA | Infectious Disease | 39 | Under 11 | $102K |
| Jose M Lares-Guia New York, NY | General Practice | 48 | 12 | $98K |
| Samuel T Merrick New York, NY | Internal Medicine | 53 | 11 | $95K |
| Audrey W Brown Columbus, GA | Internal Medicine | 51 | 12 | $94K |
| James A Zachary Austin, TX | Internal Medicine | 44 | Under 11 | $91K |
| Michael Olivier-de la Torre New York, NY | Nurse Practitioner | 43 | Under 11 | $91K |
| Steven Johnson Aurora, CO | Infectious Disease | 52 | 11 | $90K |
| Tanya Ellman New York, NY | Infectious Disease | 40 | Under 11 | $88K |
| Thomas P Poirier Gainesville, FL | Infectious Disease | 38 | Under 11 | $86K |
| Michael P Mullen New York, NY | Infectious Disease | 31 | 11 | $85K |
| Jill A Douglas Stony Brook, NY | Nurse Practitioner | 44 | Under 11 | $84K |
| Gary M Cox Durham, NC | Infectious Disease | 35 | Under 11 | $84K |
| Rita M Kelly East Setauket, NY | Nurse Practitioner | 41 | Under 11 | $78K |
| Paula A Eckardt Hollywood, FL | Infectious Disease | 37 | Under 11 | $76K |
| Stuart W Haber New York, NY | Internal Medicine | 19 | Under 11 | $74K |
| Gerald T Field I Elmhurst, NY | Nurse Practitioner | 34 | Under 11 | $72K |
| Debra L Gase Saint Louis, MO | Nurse Practitioner | 33 | Under 11 | $70K |
| Karam C Mounzer Philadelphia, PA | Internal Medicine | 28 | Under 11 | $70K |
| Kimberly A Workowski Atlanta, GA | Infectious Disease | 35 | Under 11 | $70K |
| Spending |
|---|
| Janssen Product JNJ | 12,315 | $24.7M |